Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Asthma under the microscope: 2,500 patients enrolled in landmark Real-World study

NCT ID NCT07556159

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 09, 2026 · Updated 6 times

Summary

This study is observing 2,500 people with asthma to learn more about their symptoms, treatments, and quality of life in everyday settings. Participants will fill out surveys and may provide blood samples or lung function tests. The goal is to better understand how asthma affects people differently and how it changes over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand asthma patterns and improve treatment strategies for different patient groups.
What could go wrong
This is an observational study, not a treatment trial. It collects data but does not test any new drug or intervention, so it won't directly change patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Apr 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Enrollment into Part 1 is planned to achieve a balanced distribution of participants across participating regions, to the extent feasible. In addition, enrollment is intended to include pediatric participants, adolescents, and adults. Enrollment into Part 2 is planned to achieve a balanced distribution of participants across participating regions, to the extent feasible.

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Applicable for Part 1 participants: * Age 6 years and older, at the time of signing the informed consent * Physician diagnosis of asthma for at least 12 months * Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps * Participant or legally authorized representative (where applicable) has consented to participate Applicable for Part 2 participants: * Age 18 years and older, at the time of signing the informed consent. * Physician diagnosis of asthma for at least 12 months * Existing treatment with low or medium ICS and other asthma therapies as reflected in GINA 2-4 steps * Participant or legally authorized representative (where applicable) has consented to participate * Participants must meet the criteria for at least one of the cohorts below: A) Asthma control cohorts 1. ACQ-5 \>= 1.5 2. ACQ-5 \< 1.5 (B) Type-2 biomarker cohorts 3. Elevated T2 biomarkers (B1: Type-2-high cohort) 4. Low T2 biomarkers (B2: Type-2-low cohort) Participants are excluded from the study if any of the following criteria apply (applicable for both Part 1 and Part 2 participants): * Current diagnosis of chronic obstructive pulmonary disease (COPD) or congestive heart failure * Participants with moderate/severe cognitive impairment. * Participants with moderate/severe cardiac disease. * Participants on immunosuppressive medication for a chronic condition. * Participation in other interventional and noninterventional clinical study (currently or in the past 3 months) The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    60 sites in 3 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • 3SYNC Research - Boca Raton - Site Number: 840148

    RECRUITING

    Boca Raton, Florida, 33431, United States

  • 3SYNC Research - Miami Lakes - Site Number: 840146

    RECRUITING

    Miami Lakes, Florida, 33014, United States

  • Allergy Associates, PA dba Allergy, Asthma and Sinus Center - Site Number: 840144

    RECRUITING

    Tennessee City, Tennessee, 30909, United States

  • Allergy Partners of Western North Carolina - Site Number: 840131

    RECRUITING

    Asheville, North Carolina, 28801, United States

  • Allergy and Clinical Immunology Associates - Site Number: 840127

    RECRUITING

    Pittsburgh, Pennsylvania, 15241, United States

  • Avita Clinical Research - Tampa - Site Number: 840125

    RECRUITING

    Tampa, Florida, 33613, United States

  • Bellingham Asthma, Allergy & Immunology Clinic - Site Number: 840138

    RECRUITING

    Bellingham, Washington, 98225, United States

  • Biscayne Clinical Research - Site Number: 840157

    RECRUITING

    North Miami Beach, Florida, 33169, United States

  • Bluegrass Allergy Care - Lexington - Site Number:840112

    RECRUITING

    Lexington, Kentucky, 40509, United States

  • CTMD Research, Inc - Site Number: 840147

    RECRUITING

    Palm Springs, Florida, 33406, United States

  • Care Research Inc. - Site Number: 840103

    RECRUITING

    Miami, Florida, 33130, United States

  • Chandler Clinical Trials - Site Number: 840106

    WITHDRAWN

    Chandler, Arizona, 85224, United States

  • Clinical Research of California - Site Number: 840145

    RECRUITING

    Walnut Creek, California, 94598, United States

  • Clinical Research of Gastonia (CRG) - Site Number: 840160

    RECRUITING

    Gastonia, North Carolina, 28054-7489, United States

  • Clinical Research of Rock Hill - Site Number: 840115

    RECRUITING

    Rock Hill, South Carolina, 29732, United States

  • Cornerstone Research Institute, LLC - Site Number: 840152

    RECRUITING

    Altamonte Springs, Florida, 32701, United States

  • Correa Research Center, Inc. - Site Number: 840141

    RECRUITING

    Miami, Florida, 33186, United States

  • D&H National Research Centers INC - Site Number: 840128

    RECRUITING

    Miami, Florida, 33155, United States

  • DM Clinical - Tomball - Site Number: 840130

    RECRUITING

    Tomball, Texas, 77081, United States

  • Del Sol Research Management, LLC - Mesa - Site Number: 840123

    RECRUITING

    Mesa, Arizona, 85206, United States

  • Deluxe Health Center - Site Number: 840117

    RECRUITING

    Miami Lakes, Florida, 33014, United States

  • Downtown LA Research - Site Number: 840161

    RECRUITING

    Los Angeles, California, 90017, United States

  • EMDA Clinical Research - Site Number: 840113

    RECRUITING

    Miami, Florida, 33126, United States

  • Edward Jenner Research Group, LLC - Site Number: 840169

    RECRUITING

    Plantation, Florida, 33317, United States

  • El Paso Pulmonary Association (EPPA) - West El Paso - Site Number: 840108

    RECRUITING

    El Paso, Texas, 79902, United States

  • FOMAT - Huntington Asthma & Allergy Center - Site Number: 840158

    RECRUITING

    California City, California, 91107, United States

  • Finger Lakes Medical Research, PLLC - Site Number: 840155

    RECRUITING

    Cortland, New York, 13045, United States

  • Finlay Medical Research - Miami - Site Number: 840110

    RECRUITING

    Miami, Florida, 33126, United States

  • Finlay Medical Research - Site Number: 840107

    RECRUITING

    Greenacres City, Florida, 33467, United States

  • Icahn School of Medicine at Mount Sinai - Center for Advanced Medicine - Site Number: 840119

    RECRUITING

    New York, New York, 10029, United States

  • Imax Clinical Trials - Site Number: 840109

    RECRUITING

    La Palma, California, 90623, United States

  • Investigational Site Number: 124201

    RECRUITING

    Windsor, Ontario, N8X 2G1, Canada

  • Investigational Site Number: 124203

    RECRUITING

    Calgary, Alberta, T3R 1W7, Canada

  • Investigational Site Number: 392702

    RECRUITING

    Takamatsu, Kagawa-ken, 761-8073, Japan

  • Investigational Site Number: 392705

    RECRUITING

    Kitakyushu-Shi, Fukuoka, 802-0083, Japan

  • L&A Morales Healthcare, Inc - Site Number: 840102

    RECRUITING

    Miami, Florida, 33142, United States

  • Lumi Research - Hurst - Site Number: 840164

    RECRUITING

    Hurst, Texas, 76054, United States

  • Lumi Research - Site Number: 840156

    RECRUITING

    Houston, Texas, 77090, United States

  • Mark J. Pamer D.O., LLC - Site Number: 840121

    RECRUITING

    Port Saint Lucie, Florida, 34986, United States

  • MedCorps Asthma and Pulmonary Specialists LLC - Sewell - Site Number: 840136

    RECRUITING

    Sewell, New Jersey, 08080, United States

  • MedOne Clinical Research - Site Number: 840122

    RECRUITING

    Miami, Florida, 33145, United States

  • MedQuest Translation Sciences, LLC - Site Number: 840162

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Meris Clinical Research - Site Number: 840167

    RECRUITING

    Brandon, Florida, 33511, United States

  • Mid Hudson Medical Research, PLLC - Site Number: 840139

    RECRUITING

    New Windsor, New York, 12553, United States

  • Montana Medical Research - Site Number: 840137

    RECRUITING

    Missoula, Montana, 59808, United States

  • Newport Native MD, Inc. - Site Number: 840101

    RECRUITING

    Newport Beach, California, 92663, United States

  • NexGen Research - Site Number: 840154

    RECRUITING

    Lima, Ohio, 45801, United States

  • Next Innovation Clinical Research - Chicago - Site Number: 840159

    RECRUITING

    Chicago, Illinois, 60616, United States

  • Palm Beach Medical & Research Center, Inc. - Site Number: 840165

    RECRUITING

    West Palm Beach, Florida, 33409, United States

  • Pasadena Clinical Trials - Site Number: 840116

    RECRUITING

    Pasadena, California, 91101, United States

  • Pioneer Research Solutions - Site Number: 840104

    RECRUITING

    Houston, Texas, 77099, United States

  • Primary Clinical Research, LLC - Papillion - Site Number: 840168

    RECRUITING

    Papillion, Nebraska, 68046, United States

  • Pro Care Research Center - Site Number: 840143

    RECRUITING

    Miami Gardens, Florida, 33014, United States

  • Research Institute Of South Florida - Site Number: 840149

    RECRUITING

    Miami, Florida, 33173, United States

  • Southwest Family Medicine Associates - Site Number: 840126

    RECRUITING

    Dallas, Texas, 75235, United States

  • Sun City Clinical Trials - Elite - Site Number: 840120

    RECRUITING

    Sun City, Arizona, 85351, United States

  • TBC Research Corp - Site Number: 840132

    RECRUITING

    Tamarac, Florida, 33321, United States

  • The Allergy Center at Brookstone - Site Number: 840114

    RECRUITING

    Columbus, Georgia, 31904, United States

  • Toledo Institute of Clinical Research Inc - Site Number: 840105

    RECRUITING

    Toledo, Ohio, 43617, United States

  • Valencia Medical & Research Center, Corp - Site Number: 840153

    RECRUITING

    Miami, Florida, 33174, United States

  • Valiance Clinical Research (JPJ Research) - Site Number: 840135

    WITHDRAWN

    Tarzana, California, 91356, United States

  • Velocity Clinical Research - Rockville - Site Number: 840163

    RECRUITING

    Rockville, Maryland, 20854, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.